Advertisement

Psychopharmacology

, Volume 187, Issue 3, pp 291–292 | Cite as

Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.

  • Herbert D. Kleber
Commentary

The decade of the 1960s began the current era of heavy drug use in America, beginning perhaps with Timothy Leary’s Pied Piper invitation to, “Turn On, Tune In, Drop Out” (with psychedelic drugs). While fortunately most youths who experimented did not suffer lasting damage, those of us on the mental health front lines at the time saw a number of casualties (Kleber 1967). Eventually, the hippies and the LSD-fueled “Summer of Love” in San Francisco were replaced by motorcycle gangs, amphetamines, and gratuitous violence. Psychedelic drugs receded into a permanent background of US drug use, never going away altogether, but not reaching the same penetration.

Unfortunately, one of the lasting casualties of the street use of these agents was research. Sandoz, the manufacturer of LSD, discontinued supplying it to researchers around 1965, concerned that the company’s reputation was being tainted by the illicit use. Even though street chemists supplied the vast majority of the illicit use, the...

Keywords

Methylphenidate Mystical Experience Psilocybin Meaningful Experience Improve Drug Abuse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Blum R et al (1964) Utopiates: the use and users of LSD-25. Atherton, NYGoogle Scholar
  2. Huxley A (1954) The doors of perception. Harper & Row, NYGoogle Scholar
  3. Kleber HD (1967) Prolonged adverse reactions from unsupervised use of hallucinogenic drugs. J Nerv Ment Dis 144(4):308–319CrossRefGoogle Scholar
  4. Osmond H (1993) In a letter quoted in “Entheogens and the future of religion” In: Forte R (ed) Council on spiritual practices (1997). CSP, San Francisco, p 152Google Scholar
  5. Pahnke WN (1969) Psychedelic drugs & mystical experience. Int Psychiatry Clin 5:149–162PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.College of Physicians and SurgeonsColumbia UniversityNew YorkUSA
  2. 2.Division on Substance AbuseNew York State Psychiatric InstituteNew YorkUSA

Personalised recommendations